Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate-day versus daily ferrous sulphate for iron deficiency anemia in young Omani women
ACTRN12626000398303Phase 4Not yet recruiting
- Sponsor
- Sultan Qaboos University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferrous sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by Sultan Qaboos University. Primary endpoint: Change in hemoglobin level from baseline. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12626000398303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000398303.